Physician profile
Ryan J Mazzone
NPI 1689087140
$2,806.48
in general payments reported to CMS, 2019-2025
18 companies · $281 in 2025
The $281 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $747 · 2022: $418 · 2023: $632 · 2024: $728 · 2025: $281.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,635 · Education: $6.23.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,635.05 |
| Education | $6.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $795.56 | 2021-2025 | Tezspire, Fasenra, Airsupra |
| Glaxosmithkline, LLC. | $498.72 | 2021-2024 | Nucala |
| Abiomed | $226.32 | 2024 | Impella |
| Edwards Lifesciences Corporation | $176.37 | 2022 | |
| Atricure, INC. | $173.50 | 2025 | Atricure Cryoice Cryoablation System (Cryo2), Epi-Sense Guided Coagulation System With Visitrax, Atricure Cryoice Cryosphere Cryoablation System |
| Grifols USA, LLC | $166.47 | 2021 | |
| Getinge USA Sales, LLC | $129.71 | 2023 | Vasoview Hemopro 2 |
| Boston Scientific Corporation | $124.47 | 2022 | |
| Movair INC | $123.60 | 2024 | Luisa |
| Regeneron Healthcare Solutions, INC. | $97.42 | 2023 | Dupixent |
| Pacira Pharmaceuticals Incorporated | $93.55 | 2021 | |
| Ani Pharmaceuticals, INC. | $53.80 | 2023 | Purified Cortrophin Gel |
| Amgen INC. | $40.82 | 2022-2023 | Tezspire |
| Pfizer INC. | $27.09 | 2022 | |
| Actelion Pharmaceuticals US, INC. | $27.08 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $26.56 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.20 | 2021 | |
| Sandoz INC. | $12.24 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Mazzone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.